Skip to main content
. 2018 Mar 7;9:335. doi: 10.3389/fimmu.2018.00335

Table 7.

Seroprevalence of AdHu5 and AdC68 neutralizing antibody in different age groups.

Age groups (years) N AdHu5 (%) AdC68 (%) P-value
Total samples
18–39 36 20 (55.56) 9 (25.00) 0.008
40–49 113 69 (61.06) 32 (28.32) 0.000
50–59 218 152 (69.72) 84 (38.53) 0.000
 ≥60 274 200 (72.99) 115 (41.97) 0.000
Healthy adult volunteers
18–39 11 8 (72.73) 1 (9.09) 0.002
40–49 27 18 (66.67) 7 (25.93) 0.003
50–59 74 58 (78.38) 16 (21.62) 0.000
≥60 92 62 (67.39) 24 (26.09) 0.000
Cancer patients
18–39 25 12 (48.00) 8 (32.00) 0.248
40–49 86 51 (59.30) 25 (29.07) 0.000
50–59 144 94 (65.28) 68 (47.22) 0.002
≥60 182 138 (75.82) 91 (50.00) 0.000